title: Evolution of prevalence of depressive symptoms and antidepressant use between 1988 and 1999 in a large sample of older French people: Results from the personnes agées quid study.
abstract: OBJECTIVE
  To describe the evolution of prevalence of depressive symptoms and antidepressant use between 1988 and 1999 in a large representative sample of older community-dwelling French people.
  
  
  METHODS
  Prospective cohort designed in 1988/89 to study cerebral and functional aging.
  
  
  METHODS
  Urban and rural communities in southwestern France.
  
  
  METHODS
  Three thousand six hundred thirty-seven adults aged 65 and older living in noninstitutional settings at baseline.
  
  
  METHODS
  Participants were interviewed 3, 5, 8, and 10 years after the initial data collection. Depressive symptomatology was evaluated using a French version of the Center for Epidemiological Studies Depression Scale. Longitudinal analysis of the prevalence of depressive symptomatology was performed using a logistic mixed model adjusted for antidepressant use, sex, age, education level, living conditions, psychiatric antecedents, drug consumption, and diagnosis of dementia.
  
  
  RESULTS
  Over the 10 years of follow-up, the prevalence of depressive symptomatology decreased from 13.8% to 8.3%. This decrease was statistically significant even after adjustment (odds ratio = 0.88 per increased year, 95% confidence interval = 0.85-0.90) and was more pronounced in subjects having reported previous depression at baseline. During the same period, antidepressant use rose from 5.2% to 11.9%, mainly due to increased use of selective serotonin reuptake inhibitors. Furthermore, the proportion of subjects who had depressive symptoms and did not use antidepressants decreased from 11.8% to 6.2%.
  
  
  CONCLUSIONS
  This study suggests better management of late-life depression in the last decade and illustrates the heterogeneity of depression disorder in late life.
authors.affiliation: Department of Geriatrics, CHU Bordeaux, Hôpital Xavier Arnozan, Pessac, France. dmontagnier@free.fr
authors.forename: Delphine
authors.initials: D
authors.lastname: Montagnier
authors.forename: Pascale
authors.initials: P
authors.lastname: Barberger-Gateau
authors.forename: Hélène
authors.initials: H
authors.lastname: Jacqmin-Gadda
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Dartigues
authors.forename: Muriel
authors.initials: M
authors.lastname: Rainfray
authors.forename: Karine
authors.initials: K
authors.lastname: Pérès
authors.forename: Nathalie
authors.initials: N
authors.lastname: Lechevallier-Michel
authors.forename: Annie
authors.initials: A
authors.lastname: Fourrier-Réglat
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000928:Antidepressive Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D003863:Depression / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D005602:France / Q000453:epidemiology; D005853:Geriatrics; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D015995:Prevalence; D012424:Rural Population; D013997:Time Factors; D014505:Urban Population
chemical_list: D000928:Antidepressive Agents